Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03085823Completed

The All-comers Sirolimus-coated Balloon European Registry

Role: lead

NCT03899818Not ApplicableCompleted

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment

Role: lead

NCT02298413Unknown

Italian Absorb Registry

Role: collaborator

NCT00637910Phase 3Unknown

Tarceva Italian Lung Optimization tRial

Role: lead

All 4 trials loaded